Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-20-038891
Filing Date
2020-11-24
Accepted
2020-11-23 20:44:06
Documents
14

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea130363-s1_americanbrivisi.htm S-1 2495084
2 LEGAL OPINION OF HUNTER TAUBMAN FISCHER & LI LLC ea130363ex5-1_american.htm EX-5.1 9897
3 AMENDMENT TO CO-DEVELOPMENT AGREEMENT WITH RGENE ea130363ex10-17_american.htm EX-10.17 9584
4 CONSENT OF KCCW ACCOUNTANCY CORP ea130363ex23-2_american.htm EX-23.2 3521
5 CHARTER OF THE AUDIT COMMITTEE ea130363ex99-1_american.htm EX-99.1 64048
6 CHARTER OF THE COMPENSATION COMMITTEE ea130363ex99-2_american.htm EX-99.2 20984
7 CHARTER OF THE NOMINATING AND CORPORATE GOVERNANCE COMMITTEE ea130363ex99-3_american.htm EX-99.3 21549
8 GRAPHIC image_001.jpg GRAPHIC 3279
9 GRAPHIC image_002.jpg GRAPHIC 44611
10 GRAPHIC image_003.jpg GRAPHIC 26957
11 GRAPHIC image_004.jpg GRAPHIC 44611
12 GRAPHIC image_005.jpg GRAPHIC 11888
13 GRAPHIC ex23-2_001.jpg GRAPHIC 9649
14 GRAPHIC image_006.jpg GRAPHIC 6909
  Complete submission text file 0001213900-20-038891.txt   2830568
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-250899 | Film No.: 201339601
SIC: 2834 Pharmaceutical Preparations